Ticker Details
Eton Pharmaceuticals, Inc. Common Stock
IPO Date:	November 13, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$892.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 2.73%
Avg Daily Range (30 D):	$0.90 | 3.20%
Avg Daily Range (90 D):	$0.58 | 2.57%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.31M

Trade Size
Avg Trade Size (Sh.):	112
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	139
Avg Institutional Trade:	$1.38M
Avg Institutional Trade (30 D):	$1.06M
Avg Institutional Trade (90 D):	$1.02M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.53M
Avg Closing Trade (30 D):	$1.08M
Avg Closing Trade (90 D):	$1.07M
Avg Closing Volume:	103.96K

News

Mar 2, 2026 @ 12:27 PM Eton Pharmaceuticals Expands Rare Disease Portfoli... Source: Globe Newswire

Feb 25, 2026 @ 6:47 PM Eton Pharmaceuticals Announces U.S. FDA Approval f... Source: Na

May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals

May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals

Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.05	$.06	$.06
Diluted EPS		$.05
Revenue	$86.93M	$24.27M	$21.28M
Gross Profit	$47.61M	$14.74M	$13.1M
Net Income / Loss	$-1.48M	$1.55M	$1.48M
Operating Income / Loss	$2.04M	$2.41M	$2.46M
Cost of Revenue	$39.32M	$9.53M	$8.18M
Net Cash Flow	$4.73M	$-6.28M	$-11.18M
PE Ratio